Recruiting studies: Cervical Cancer By Figo Stage 2018

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Phase II Study on Neoadjuvant Therapy of AK104 Combined With Nab-paclitaxel/Carboplatin in Fertility Preserving Surgery
Phase 2 · 1 location(s) · Xiaohua Wu · NCT06209294 Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix
NA · 5 location(s) · Varian, a Siemens Healthineers Company · NCT05197881 Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance C
Phase 3 · 301 location(s) · National Cancer Institute (NCI) · NCT07061977 FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
NA · 4 location(s) · University Health Network, Toronto · NCT04016389 A Radiomic MRI Predictive Model for Response to Concomitant Chemoradiotherapy in Locally Advanced Cervical Cancer
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire de Nīmes · NCT07305727 Concurrent Chemoradiotherapy Combined With Adjuvant Chemotherapy Treated Advanced Cervical Cancer
Phase 3 · 1 location(s) · Fourth Affiliated Hospital of Guangxi Medical University · NCT05735145

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.